NF-κB-mediated upregulation of MHC-I is believed to enhance T-cell activation (46); this may increase tumor cell recognition, ultimately making the melanoma cells more susceptible to cytotoxic CD8+ T-cell killing. This evidence concerns the gene NFKB1 and melanoma.